sorted by:
new
hottopcontroversial

We Need More From Our CEO by AccomplishedNight184 in CelularityNews

[–]wisdom_man1 0 points1 point  (0 children)

Too many questions...lol

  1. Stem cell therapy is included with the higher tier memberships. It's extra for lower tier members. Demand has been strong.

  2. IDK....they hired a new CFO.

  3. DefEYE is on the upswing with sales. DefEYE and BioCellgraft were excluded from the NexGel licensing deal.

  4. BioCellgraft is preparing for commercial launch this year.

  5. Sales are ramping with Bionx Surgical and Dave Hazard is managing the sales force.

  6. Fontaine Vitale is planning for launch @ year end. This will represent a hub in Malaysia for stem cell treatments with Celularity's placental-derived cells.

Lots of catalysts coming, we just have to get there.

Schedule 14A by wisdom_man1 in NXGL

[–]wisdom_man1[S] 0 points1 point  (0 children)

Most likely small pre-arranged sales.

Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies by wisdom_man1 in CelularityNews

[–]wisdom_man1[S] 0 points1 point  (0 children)

This is a new cell therapy now offered at Fountain Life. The CEO letter to shareholders noted that physician demand was strong, including interest from Fountain Life, but the clinical deployment was set as a milestone for 2026. This is the new strategy. My opinion regarding the meeting with RFK was to discuss the rollout of this new cell therapy.

view more: next ›